A Pilot Study of Time Restricted Diet in Obese/Overweight Pre &Amp; Postmenopausal Women
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 45
- 试验地点
- 2
- 主要终点
- Attaining the goal of dietary time restriction
研究概览
简要总结
The purpose of this study is to study the relationships between obesity, hormones and menopausal status, and breast cancer. The researchers would like to study whether a type of nutritional intervention, called a time-restricted diet or tRD, is easy to maintain using a smartphone application; the researchers also want to study the effect that a tRD has on weight control, hormones, and breast tissue. A tRD is a type of diet that requires people to restrict their daily eating to a specific time frame each day. The researchers think that this might be an effective and manageable way to control weight.
详细描述
PRIMARY OBJECTIVES:
I. Feasibility of fostering adherence to self-monitoring of dietary intake using a smartphone application (app).
II. Feasibility of the goal of following a time-restricted diet.
SECONDARY OBJECTIVES:
I. Identify potential molecular biomarkers and/or signatures to explore its efficacy for the normalization of metabolism.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Subjects must have a stable weight (have not gained or lost 25 pounds in the last 6 months)
- •Subjects must have had a normal mammogram within 9 months prior to registration; NOTE: subjects must also have a normal breast exam on the day of the pre-intervention random fine needle aspiration (rFNA)
- •Subjects must have a body mass index (BMI) of 25-40
- •Subjects must fit into ONE of the following menopausal categories:
- •Premenopausal (n = 40) - defined as meeting all the following criteria:
- •Have had at least 8 menstrual cycles in the past 12 months
- •Have had no hormonal contraception in the past 3 months prior to registration
- •Have serum hormone parameters (estradiol [E2], progesterone, follicle stimulating hormone [FSH]) in premenopausal range on the day of rFNA; NOTE: subjects will self-report menopausal status at registration, and confirmation of hormonal parameters will occur after registration as part of pre-intervention procedures; if there is mis-assignment of status, the recruitment of future subjects will be adjusted accordingly
- •Postmenopausal (n = 40) - defined as meeting all of the following criteria:
- •Last menstrual period (LMP) > 1 year previously
- •Have had no hormone use in the past 3 months prior to registration
- •Serum E2, progesterone, FSH in postmenopausal range on the day of rFNA; NOTE: subjects will self-report menopausal status at registration, and confirmation of hormonal parameters will occur after registration as part of pre-intervention procedures; if there is mis-assignment of status, the recruitment of future subjects will be adjusted accordingly
- •Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- •Subjects who have been diagnosed with a prior cancer at any site (other than breast cancer) may participate as long as they have been off medical therapy for at least 12 months prior to registration
- •Subjects with prior breast cancer must be off all systemic therapy (including endocrine agents) for at least 2 years prior to registration
- •Subjects must be willing to undergo a random fine needle aspiration (rFNA) at the beginning and end of the intervention period
- •Subjects must be willing and able to abstain from the use of aspirin for at least 2 weeks prior to undergoing each rFNA procedure (pre- and post-intervention)
- •Subjects must have the ability to understand and the willingness to sign a written informed consent prior to registration on study
- •Subjects must have a smart phone (newer generation Android or any Iphone) to be able to track their food intake times
- •Subjects must be willing to restrict food intake to an 8 hour period every day (12 pm to 8 pm)
排除标准
- •Subjects who have received hormonal contraception and/or hormone therapy in the past 3 months are not eligible
- •Subjects who are pregnant and/or lactating are not eligible
- •Subjects who are noted (upon initial online screening) to do 150 minutes or more of moderate level physical activity each week, get less than 8% of their calories from saturated fat, and eat more than 5 fruit and vegetable servings per day will not be eligible
- •Subjects who are part of any structured weight loss programs (e.g. Weight Watchers, etc.) are not eligible
- •Subjects who have undergone bariatric surgery are not eligible
- •Subjects who work night shifts are not eligible
- •Subjects who have diabetes or uncontrolled hypertension are not eligible; NOTE: for the purposes of this study, uncontrolled will be defined as diastolic pressure over 100 mmHg
结局指标
主要结局
Attaining the goal of dietary time restriction
时间窗: Up to 3 months after completion of study
Assessed by demonstrating that at least 65% of participants recorded appropriate time restriction on at least 80% of study days.
Adherence to self-monitoring
时间窗: Up to 3 months after completion of study
Assessed by demonstrating that at least 65% of participants record dietary intake on at least 80% of study intervention days. Adherence will be assessed via a one-sample chi-squared test for proportions.
次要结局
- Changes in breast epithelial gene expression(Baseline to up to 3 months after completion of study)
- Changes in parenchymal volume assessed by MRI(Baseline to up to 3 months after completion of study)
- Changes in steroid hormones (estradiol, progesterone, testosterone) levels(Baseline to up to 3 months after completion of study)
- Changes in gonadotropins (FSH) levels(Baseline to up to 3 months after completion of study)
- Changes in insulin axis (insulin, insulin-like growth factor 1, IGF binding protein 3, homeostatic model assessment, homocystein) levels(Baseline to up to 3 months after completion of study)
- Changes in adipokines (leptin, adiponectin, low molecular weight adiponectin) levels(Baseline to up to 3 months after completion of study)
- Changes in inflammatory axis (interleukin-6, tumor necrosis factor alpha) levels(Baseline to up to 3 months after completion of study)
- Changes in weight(Baseline to up to 3 months after completion of study)
- Changes in BMI(Baseline to up to 3 months after completion of study)